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ThehumanDNAdamagesensors,Rad17-replicationfactorC (Rad17-
RFC) and the Rad9-Rad1-Hus1 (9-1-1) checkpoint complex, are
thought to be involved in the early steps of the DNA damage
checkpoint response. Rad17-RFC and the 9-1-1 complex have been
shown to be structurally similar to the replication factors, RFC
clamp loader and proliferating cell nuclear antigen polymerase
clamp, respectively. Here, we demonstrate functional similarities
between the replication and checkpoint clamp loaderDNA clamp
pairs. When all eight subunits of the two checkpoint complexes are
coexpressed in insect cells, a stable Rad17-RFC9-1-1 checkpoint
supercomplex forms in vivo and is readily purified. The two
individually purified checkpoint complexes also form a supercom-
plex in vitro, which depends on ATP and is mediated by interactions
between Rad17 and Rad9. Rad17-RFC binds to nicked circular,
gapped, and primed DNA and recruits the 9-1-1 complex in an
ATP-dependent manner. Electron microscopic analyses of the
reaction products indicate that the 9-1-1 ring is clamped around
the DNA.
Eukaryotic cells exposed to genotoxic agents activate the DNAdamage checkpoint signaling pathway, which arrests cell-
cycle progression and in so doing prevents cell death or muta-
tions. Recent work has revealed that in mammalian cells, the
ATM and ATR proteins, which belong to the phosphatidyli-
nositide kinase-like kinase family, and the Rad17-replication
factor C (Rad17-RFC) and the Rad9-Rad1-Hus1 (9-1-1) check-
point complexes, which have structural similarities to the repli-
cation clamp loader and replication clamp RFC and proliferating
cell nuclear antigen (PCNA), respectively, are involved in dam-
age recognition, which activates the checkpoint response (re-
viewed in refs. 1–4). Studies with budding and fission yeasts have
shown that the orthologs of these proteins perform similar
functions. However, biochemical data on the specific roles of the
phosphatidylinositide kinase-like kinase family members and
the Rad17-RFC and 9-1-1 complexes are scarce, and hence the
damage sensing step of the checkpoint response remains ill-
defined. We previously reported that ATR directly recognizes
and is activated by damaged DNA (5). In this article, we
investigate the interactions of Rad17-RFC and the 9-1-1 check-
point complexes with DNA to gain some insight into their roles
as damage sensors.
Rad17-RFC is one of the three known RFC-like complexes in
mammalian cells. In this form of RFC, the p140 subunit is
replaced by the 75-kDa Rad17 protein, which has homology to
all RFC subunits (6). Yeast genetic studies indicate that the
orthologs of human Rad17 function exclusively in the DNA
damage checkpoint response (7, 8). The 9-1-1 checkpoint com-
plex is a heterotrimer of Rad9, Rad1, and Hus1 proteins, which
were predicted to have structural homology to PCNA (9–13).
Previously, we showed that Rad17 associates with the four small
RFC subunits to make an RFC-like complex, which by electron
microscopy exhibits an RFC-like structure (14). Similarly, we
found that Rad9, Rad1, and Hus1 form a heterotrimeric complex
with a PCNA-like ring structure (14). During replication, RFC
binds to primed templates and recruits PCNA to the site of
replication (reviewed in ref. 15). RFC opens the PCNA ring and
closes it around the DNA at the primertemplate junction, where
PCNA acts as a polymerase clamp and a processivity factor for
DNA polymerases  and . Despite the structural similarities
between the RFCPCNA and Rad17-RFC9-1-1 complex pairs,
at present there is no direct biochemical evidence that Rad17-
RFC and the 9-1-1 ring function in a manner analogous to their
replicative counterparts. In this study, we investigated the inter-
actions of Rad17-RFC with the 9-1-1 complex and the binding
of these proteins to DNA. We find that Rad17-RFC binds to the
9-1-1 complex in an ATP-dependent manner and that the
interaction is mediated mainly by binding of Rad9 to Rad17. By
using nicked and gapped plasmid DNAs, we find that the binding
of Rad17-RFC to DNA is ATP-independent but that the re-
cruitment of the 9-1-1 complex depends on ATP but does not
require ATP hydrolysis. Electron microscopic analysis of the
DNA–protein complexes suggests that Rad17-RFC does in fact
load the 9-1-1 complex on DNA.
Materials and Methods
Expression and Purification of Recombinant Proteins. Baculoviruses
used for expression of Flag-Rad17, His-Rad17, His-p140, p40,
His-p38, p37, p36, Flag-Rad9, Rad9, Flag-Hus1, Hus1, and Rad1
were described (6). Infection of monolayer High Five (H5) insect
cells (Invitrogen) and isolation of 9-1-1, Rad17-RFC, and the
9-1-1Rad17-RFC complexes were as described (6, 14).
Rad1 baculovirus expressing the Rad1 with a Flag2-cAMP
kinase site motif (LRRASV) at the N terminus was constructed
by inserting a linker containing Flag-cAMP kinase motif se-
quence at the 5 terminus of pFastBac1-Rad1 (6) and generating
the baculovirus by using the Bac-to-Bac System (Invitrogen).
Monolayer H5 insect cells (1  109 cells, Invitrogen) were
infected with a multiplicity of infection of five for baculoviruses
expressing Rad9, Hus1, and Flag-cAMP kinase motif-tagged
Rad1 and were harvested 48 h after infection. The packed cells
(7.5 ml) were washed with ice-cold PBS, lysed in 15 ml of
hypotonic buffer (50 mM TrisHCl, pH 8.010 mM sodium
phosphate, pH 8.01.5 mM MgCl21 mM DTT2 g/ml apro-
tinin2 g/ml leupeptin2 g/ml antipain0.1 mM benzamidine
0.5 mM PMSF) supplemented with 10 mM KCl by Dounce
homogenization (10 strokes with a B pestle) and centrifuged at
2,400  g for 30 min at 4°C. The supernatant (cytosolic fraction)
was adjusted to 0.5 M NaCl. The pellet was resuspended in 15 ml
of hypotonic buffer containing 0.5 M NaCl and centrifuged at
43,500  g for 30 min at 4°C. The supernatant (nuclear fraction)
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and the cytosolic fraction were combined and centrifuged for 15
min at 43,500  g at 4°C. Flag-M2 beads (Sigma, 0.75 ml),
equilibrated with 50 mM TrisHCl, pH 8.020 mM sodium
phosphate, pH 8.00.5 M NaCl1 mM DTT2 g/ml aprotinin2
g/ml leupeptin2 g/ml antipain0.1 mM benzamidine0.5 mM
PMSF were added to the supernatant (41 ml, 360 mg), and the
suspension was rocked overnight at 4°C. The Flag M2 beads were
washed five times with 10 ml of Flag buffer (20 mM sodium
phosphate, pH 8.010% glycerol0.5 M NaCl1 mM DTT2
g/ml aprotinin2 g/ml leupeptin2 g/ml antipain0.1 mM
benzamidine0.5 mM PMSF). The bound Flag-tagged 9-1-1 was
eluted two times with 0.75 ml of Flag buffer containing 0.2
mgml Flag peptide for 45 min at 4°C, yielding 0.53 mg
of protein. The Flag-cAMP kinase-tagged 9-1-1 was labeled
with [-32P]ATP to a specific activity of 1,800 cpmfmol, as
described (16).
In Vitro Interaction of the Rad17-RFC and Checkpoint 9-1-1 Complexes.
Two assays were used to analyze the Rad17-RFC and 9-1-1
interaction. In one assay, reaction mixtures (1 ml) containing the
purified 9-1-1 complex (1 pmol) and the purified Rad17-RFC
complex (1 pmol) were incubated in buffer containing 25 mM
TrisHCl, pH 7.50.15 M NaCl10 mM MgCl21 mM DTT0.1
mg/ml BSA in the presence or absence of 1 mM ATP for 1 h at
30°C. Protein was then immunoprecipitated with 1 g of anti-
Rad9 antibodies (Santa Cruz Biotechnology) and 20 l of
protein-A agarose, followed by rotation for 2 h at 4°C; the resin
was washed three times with reaction buffer  0.05% Nonidet
P-40 (1 ml each time), and the bound and unbound proteins were
analyzed by Western blotting with anti-Flag antibodies (Sigma).
In the second assay, reaction mixtures (25 l) contained Rad17-
RFC (or RFC, 5 pmol), 32P-labeled 9-1-1 (or PCNA, 0.5 pmol),
binding buffer (25 mM Hepes-KOH, pH 7.50.1 mM EDTA1
mM DTT0.15 M NaCl0.5% Nonidet P-4010 mM MgCl21
mg/ml BSA) and 1 mM ATP, as indicated. After incubation for
10 min at 37°C, an aliquot (10 l) was diluted 10-fold with
binding buffer and incubated with 1 g of anti-RFCp37 or
preimmune serum and 10 l of protein-A agarose (Upstate
Biochemicals) for 1 h at 4°C with constant agitation. The beads
were washed three times with 0.5 ml of binding buffer and twice
with 0.5 ml of binding buffer lacking BSA. Bound proteins were
eluted in 20 l of SDS loading buffer and subjected to 12%
SDSPAGE, and 32P-labeled 9-1-1 and PCNA were analyzed by
autoradiography.
Formation of Rad17-RFC and 9-1-1 complexes was also
analyzed by glycerol gradient sedimentation. Rad17-RFC (5
pmol) and 32P-labeled 9-1-1 (1 pmol) were incubated in 100 l
of binding buffer in the presence or absence of 10 M nucleotide
(as indicated) for 10 min at 37°C, and the mixture was layered
onto a 5-ml 15–35% glycerol gradient containing 25 mM
TrisHCl, pH 7.5, 1 mM EDTA, 0.01% Nonidet P-40, 1 mM
DTT, 10 mM MgCl2, and 50 gml BSA. The gradient was
centrifuged at 4°C for 20 h at 260,000  g, and samples were
collected from the bottom of the gradient. The distribution of
32P-labeled 9-1-1 was measured by Cerenkov counting, whereas
distribution of the Rad17-RFC in gradient fractions was de-
tected by slot blotting on nitrocellulose membrane.
Interactions Between Rad17 and Rad9. H5 insect cells (5  106)
were coinfected with baculoviruses expressing either His-Rad17
or His-RFCp140, together with Flag-Rad9, Flag-Rad1, Flag-
Hus1, or Flag-Hus1, together with untagged Rad9 and Rad1 at
a multiplicity of infection of five. After lysing the cells in 1.5 ml
of 50 mM TrisHCl, pH 7.50.3 M NaCl0.05% Nonidet P-40,
the protein was then immunoaffinity-purified by using 10 l of
anti-Flag agarose. After washing the resin three times in the
same buffer (1 ml), protein was eluted with 0.2 mgml Flag
peptide in 0.15 M NaCl, 50 mM TrisHCl, pH 7.5 and 10%
glycerol. Aliquots of the load and the eluted material were
subjected to SDS12% PAGE and Western blotting.
The Rad17-interacting domain of Rad9 was mapped by using
baculoviruses that expressed five fragments of Rad9 containing
a C-terminal Flag-tag (described in Fig. 4B) that were generated
by PCR amplification by using pFast-Flag-Rad9 (6) as the
template. These fragments were expressed in H5 cells and bound
to anti-Flag agarose. After washing the resin three times, it was
incubated with extract made from H5 cells infected with either
His-Rad17 or His-p140. After washing the resin, the bound
protein was eluted with Flag peptide and analyzed by Western
analysis with anti-His (Santa Cruz Biotechnology) and anti-Flag
antibodies.
Recruitment of Checkpoint 9-1-1 Complex to DNA by Rad17-RFC.
Reaction mixtures (50 l) containing Rad17-RFC (2 pmol),
32P-labeled 9-1-1 (0.6 pmol), 0.15 pmol of nicked pBluescript
(17), 40 mM TrisHCl, pH 7.8, 10 mM magnesium acetate, 1 mM
DTT, 0.2 mgml BSA, 2 mM [-thio]ATP (ATPS) (or ATP),
and 0.15 M NaCl were incubated for 10 min at 37°C. Reactions
were loaded onto 5 ml of Bio-Gel A-15M (0.7  15 cm) column.
The columns were eluted with 40 mM TrisHCl, pH 7.8, 0.1 mM
EDTA, 0.2 mgml BSA, 10 mM magnesium acetate, 4% glycerol,
0.15 M NaCl, 1 mM DTT, and 0.01% Nonidet P-40. The amount
of labeled 9-1-1 in the fractions (150 l each) was measured by
Cerenkov counting, and Rad17-RFC was detected by slot blot-
ting of the fractions on nitrocellulose membranes.
Electron Microscopy. Reaction mixtures (20 l) containing puri-
fied 9-1-1 (1 pmol) and Rad17-RFC (0.2 pmol) were incubated
alone or together with 100 ng of a 6.9-kb nicked plasmid
(pFastBac1-Rad17) or a 718-bp circular DNA with a 40-nt
ssDNA gap (to be described elsewhere) with 30 mM Hepes, pH
7.58 mM magnesium acetate1 mM DTT2 mM ATP5%
PEG at 37°C for 10 min. Reactions were then diluted 10-fold
with addition of NaCl to 0.5 M and EDTA to 2 mM and
incubated for 5 min at 20°C to release loosely bound proteins.
The samples were treated with 0.6% glutaraldehyde at 20°C for
5 min and chromatographed over a 2.5-ml column of Bio-Gel
A-5m, and fractions containing the DNA–protein complexes
were collected and prepared for electron microscopy (18).
Analysis was done on a Phillips CM12 instrument. Images on
negatives were scanned with a Nikon LS4500 film scanner, and
the figures were prepared by using PHOTOSHOP (Adobe Systems,
Mountain View, CA).
Results
Purification of Rad17-RFC9-1-1 Checkpoint Supercomplex. We pre-
viously showed that the Rad17-RFC and the 9-1-1 checkpoint
complexes could be expressed in baculovirus-infected insect cells
and purified in quantities sufficient for biochemical analysis (6).
We wished to determine whether these two complexes associate
when free in solution or whether they assemble on DNA
exclusively. Infection of insect cells with baculoviruses express-
ing the three subunits of the 9-1-1 complex or the five subunits
of the Rad17-RFC complex resulted in the formation of these
complexes in vivo, and the complexes were readily purified by
affinity chromatography (Fig. 1) as reported (6). Significantly,
when the insect cells were coinfected with eight different viruses,
each expressing one of the subunits, we were also able to purify
the checkpoint supercomplex Rad17-RFCRad9-Rad1-Hus1,
containing all eight subunits in essentially stoichiometric ratios,
by using affinity resins for tags on both Rad17 and Hus1 (Fig. 1,
lane 3). Thus, it seems that Rad17-RFC and the 9-1-1 checkpoint
complex can associate off DNA. Furthermore, the yield of the
eight-subunit complex assembled in vitro was unaffected by the
presence of DNA (data not presented).
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Effect of ATP on the Formation of the Rad17-RFC9-1-1 Supercomplex.
Because replicative RFC binds PCNA in an ATP-dependent
manner (19), we investigated the effect of ATP on Rad17-RFC
9-1-1 complex formation. Binding was analyzed by both protein
pull-down assays and by glycerol gradient sedimentation. The
pull-down assay was performed by immunoprecipitating Rad9 or
RFCp37 in a mixture that contained Rad17-RFC and 9-1-1, and
then probing the immunoprecipitates for either the Rad17 or
Rad1 subunits of the supercomplex. Fig. 2A shows that Rad9
antibodies coimmunoprecipitate Rad17 and presumably the
entire Rad17-RFC complex. Similarly, Fig. 2B shows that anti-
RFCp37 antibodies pull-down Rad1 and, presumably, the entire
9-1-1 complex. Although some background association is seen in
Fig. 2 A, the binding of the two complexes depends strongly on
adenosine nucleotides. Quantitative analysis of Fig. 2B shows
that binding is strongest in the presence of ATPS, followed by
ATP, dATP, and ADP, and that GTP, UTP, and CTP are
ineffective (Fig. 2C). In these experiments, the level of nucleo-
tide used was 10 M (the Km found for ATP in this reaction). In
Fig. 2D, complex formation was analyzed by glycerol gradient
sedimentation. The results confirm the data from the other
panels, and moreover, the sedimentation coefficient of the
complex reveals that in the presence of ATP or ADP, but not
AMP or adenosine 5-[,-imido]triphosphate (AMPPNP), a
stable complex assembles that is consistent with the predicted
mass of Rad17-RFC9-1-1 complex. Thus, as in the case of RFC
and PCNA, ATP binding but not hydrolysis is required for
complex formation between Rad17-RFC and the 9-1-1 ring.
Specificity of the Rad17-RFC9-1-1 Interaction. It is remarkable that
despite apparent structural similarities, the function of RFC
PCNA is restricted to replication and that of Rad17-RFC9-1-1
complex is restricted to the checkpoint. To gain some insight into
this specificity, we analyzed the interactions of RFC and Rad17-
RFC with both PCNA and the 9-1-1 complex. Fig. 3 (Upper)
shows that in the presence of ATP, Rad17-RFC, but not RFC,
is capable of binding to the 9-1-1 complex. Surprisingly, both
Rad17-RFC and RFC can bind PCNA (Fig. 3 Lower) even in the
absence of ATP. The marginal ATP stimulation of the PCNA–
RFC interaction is most likely due to the salt conditions used in
this reaction (0.15 M NaCl). The findings that Rad17-RFC can
bind both 9-1-1 and PCNA trimeric rings (as seen in Fig. 3) would
suggest that although RFC cannot substitute for Rad17-RFC in
the checkpoint response, Rad17-RFC may be capable of substi-
tuting for RFC in replication. However, we have determined that
Fig. 1. Purification of Rad17-RFC9-1-1 checkpoint supercomplex. The
checkpoint complexes were reconstituted in H5 cells by coinfection with: lane
1 (9-1-1 complex), three baculoviruses expressing Flag-Rad9, Hus1, and Rad1;
lane 2 (Rad17-RFC), five baculoviruses expressing Flag-Rad17, p40, His-p38,
p37, and p36; and lane 3 (supercomplex), eight baculoviruses expressing
His-Rad17, p40, His-p38, p37, p36, Rad9, Flag-Hus1, and Rad1. Complexes were
purified by chromatography with Ni-NTA andor anti-Flag agarose as de-
scribed in Materials and Methods, and proteins were visualized after SDS
PAGE by silver staining.
Fig. 2. Nucleotide cofactor requirement for binding of Rad17-RFC to the 9-1-1 complex. (A) Coimmunoprecipitation with anti-Rad9 antibodies. One picomole
each of purified Rad17-RFC and 9-1-1 complexes were incubated with or without ATP and immunoprecipitated with anti-Rad9 antibodies; the bound and
unbound proteins were analyzed by Western blotting with anti-Flag antibodies. (B) Coimmunoprecipitation with anti-RFCp37 antibodies. Reaction mixtures
(25 l) containing 5 pmol of purified RFC or Rad17-RFC and 0.5 pmol of 32P-labeled 9-1-1 were incubated with or without 10 M of the indicated nucleotide as
described in Materials and Methods. Lo denotes 10% input, Pr denotes preimmune serum, and 37 denotes anti-RFCp37 serum used for immunoprecipitations.
The bound proteins were eluted with SDS loading buffer, subjected to SDS12% PAGE, and autoradiographed. (C) The 32P-labeled 9-1-1 bound to Rad-17RFC
shown in B was quantitated by phosphorimaging analyses. (D) Analysis by glycerol gradient velocity sedimentation. Reaction mixtures (100 l) containing
purified Rad17-RFC (5 pmol) and 32P-labeled 9-1-1 (1 pmol) were incubated in the presence or absence of 10 M indicated nucleotides. After incubation, mixtures
were subjected to glycerol gradient centrifugation as described in Materials and Methods. Nucleotide additions were as follows: }, no ATP; {, ATP; F, ADP; ■ ,
AMP; and Œ, adenosine 5-[,-imido]triphosphate (AMPPNP).








Rad17-RFC will not substitute for RFC in an in vitro DNA
polymerase , PCNA-dependent replication reaction or in the
loading of PCNA onto DNA (data not shown). The physiological
significance of the Rad17-RFCPCNA interaction remains to be
determined.
Our data show that it is the Rad17 subunit of Rad17-RFC that
enables this complex to bind to the 9-1-1 ring. Hence, we
investigated the interaction of Rad17 with the subunits of the
9-1-1 complex. Fig. 4A shows that Rad9, and to a much lesser
degree Rad1, interacts with Rad17, but Hus1 does not. Having
thus found that Rad9 is the subunit mainly responsible for
interaction with Rad17-RFC, to the exclusion of RFC, we
examined whether the non-PCNA-like C-terminal extension of
Rad9 was responsible for the Rad17-RFC9-1-1 complex spec-
ificity. Deletion constructs missing either the amino (amino acids
1–130) or carboxyl (amino acids 260–391) terminus of Rad9
were made and tested for their interaction with Rad17. Fig. 4B
(lane F) shows, as expected, that full-length Rad9 binds to Rad17
but not to RFCp140, which replaces Rad17 in replicative RFC.
Importantly, we find that the PCNA-like domain of Rad9 (amino
acids 1–270) is necessary and sufficient for binding to Rad17
(Fig. 4B, lane C). Thus, the C-terminal non-PCNA-like extension
of Rad9 is not responsible for specific interactions with Rad17-
RFC. This extension contains the Rad9 phosphorylation sites, as
were reported (20). It is apparent from the anomalous (slow)
migration of the Rad9 fragments, which contain this region, that
it is heavily phosphorylated even when expressed in insect cells
(Fig. 4B, lanes D–F). It is possible that the C-terminal extension
is involved in the effector functions of the 9-1-1 checkpoint
complex.
Recruitment of the 9-1-1 Ring to DNA by Rad17-RFC. In vivo data in
both budding yeast and humans indicate that Rad17-RFC to-
gether with the 9-1-1 complex associate with the damage site
early on in the checkpoint response (21–23). Because Rad17-
RFC binds to DNA in vitro and the 9-1-1 complex does not, we
reasoned that the 9-1-1 ring may be recruited to the site of DNA
damage in a manner analogous to the recruitment of PCNA by
RFC to the primer terminus during replication. To test this
model, a nicked plasmid DNA was incubated with Rad17-RFC,
the 9-1-1 complex, or both, and the DNA was separated from
unbound proteins by gel-exclusion chromatography (Fig. 5).
Rad17-RFC binds DNA in the absence or presence of the 9-1-1
complex, and this binding is ATP-independent (data not shown).
In contrast, the 9-1-1 complex binds to DNA only when Rad17-
RFC is present, indicating that Rad17-RFC does recruit the
9-1-1 complex to DNA. Because the loading of PCNA onto DNA
is ATP-dependent, we investigated the nucleotide cofactor
requirement for recruitment. As apparent from Fig. 5, the
recruitment of the 9-1-1 complex to DNA by Rad17-RFC (its
elution in the excluded region) (i) requires a nicked or gapped
DNA substrate (form II), (ii) requires a nucleotide cofactor, and
(iii) is more efficient in the presence of ATPS than ATP and
is most efficient when incubated with ATPS followed by
Fig. 3. Interactions of RFC and Rad17-RFC with PCNA and the 9-1-1 check-
point complex. Reaction mixtures (25 l) containing purified Rad17-RFC or RFC
(5 pmol) and 1 pmol of either 32P-labeled 9-1-1 (Upper) or PCNA (Lower) were
incubated in the presence or absence of 1 mM ATP as described in Materials
and Methods. The 9-1-1 (or PCNA) bound to Rad17-RFC or RFC was immuno-
precipitated with anti-RFCp37 antibody, and the bound material was ana-
lyzed by SDSPAGE followed by autoradiography. Lo, 10% input; Pr, pre-
immune serum; 37, anti-RFCp37 antibody.
Fig. 4. Rad9 mediates the Rad17-RFC9-1-1 interaction. (A) Rad17 interacts
with Rad9. H5 cells were coinfected with baculoviruses expressing either
His-Rad17 alone (lane 1) or His-Rad17 together with Flag-Rad1 (lane 2),
Flag-Rad9 (lane 3), Flag-Hus1 (lane 4), or Flag-Hus1, and untagged Rad1 and
Rad9 (lane 5). The proteins were immunoaffinity purified with anti-Flag
agarose, and proteins were analyzed by Western blotting with anti-Rad17 or
anti-Flag antibodies. (B) Binding of the PCNA-like domain of Rad9 to Rad17.
The following fragments of Rad9 were produced in H5 cells and bound to
anti-Flag agarose resin: amino acids 1–130, lane A; amino acids 130–270, lane
B; amino acids 1–270, lane C; amino acids 260–391, lane D; amino acids
130–391, lane E; and full length, lane F. The resin was then incubated with
extracts made from H5 cells infected with either His-Rad17 or His-p140. After
washing the resin, bound protein was eluted with Flag peptide and analyzed
by Western blotting with anti-His and anti-Flag antibodies.
Fig. 5. Recruitment of the 9-1-1 complex to DNA by Rad17-RFC. Reaction
mixtures (50 l) containing 32P-labeled 9-1-1 (0.6 pmol), Rad17-RFC (2 pmol),
and nicked pBluescript plasmid (0.15 pmol), where indicated, were incubated
with or without nucleotide. The mixtures were then loaded onto a 5-ml BioGel
A-15M column as described in Materials and Methods. ■ , form II (nicked
plasmid)Rad17-RFC9-1-1ATPS-ATP (mixture was incubated with ATPS
for 5 min and then with 8 mM ATP for 5 min); Œ, form II (nicked plasmid)
Rad17-RFC9-1-1ATPS; F, form II (nicked plasmid)Rad17-RFC9-1-1ATP;
, form II (nicked plasmid)Rad17-RFC9-1-1; E, form II (nicked plasmid)
9-1-1ATP; , Rad17-RFC9-1-1ATPS.
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incubation with ATP. Thus, it can be concluded that ATP
binding but not ATP hydrolysis is needed for recruitment.
Loading of the 9-1-1 Ring onto DNA by Rad17-RFC. During replica-
tion, RFC binds to PCNA, opens the ring, and clamps it onto
DNA where PCNA can bind to Pol and Pol to aid in processive
DNA synthesis (15). The loading of PCNA by RFC is catalytic,
and an RFC molecule is capable of loading multiple PCNAs onto
DNA. A consequence of this mode of action is that when a
nicked or gapped circular DNA is used for PCNA recruitment,
multiple PCNAs are loaded onto the circle and slide away from
the site of loading. If the plasmid is linearized with a restriction
enzyme, the PCNA molecules not associated with RFC slide off
the DNA with the consequence of having RFC and PCNA on the
DNA at a molar stoichiometry of 1:1.
To find out whether the Rad17-RFC9-1-1 complex behaved
similarly, we performed loading experiments with these com-
plexes (Fig. 6). First, in agreement with previous reports, we
found that the amount of PCNA loaded by RFC on linearized
DNA was 5-fold lower than that loaded onto nicked circular
DNA (Fig. 6A). This is consistent with the RFC-free PCNA rings
sliding off linear DNA but not off circular DNA. However, when
similar experiments were performed with the Rad17-RFC
9-1-1 pair, only a marginal decrease in the amount of DNA-
associated 9-1-1 complexes was observed with linear DNA
compared with circular DNA (Fig. 6B). Identical results were
obtained when PCNA and 9-1-1 were loaded onto the nicked
plasmid, isolated by gel-exclusion chromatography, and then
linearized by restriction. These results, at face value, imply that
Rad17-RFC recruits the 9-1-1 ring to DNA, but it does not clamp
it around the duplex in a manner similar to PCNA. Alternatively,
the data are also consistent with a model in which the vast
majority of the DNA–protein complexes in the Rad17-RFC
9-1-1 reaction mixture contain both the clamp loader and the
clamp, and hence the clamp cannot escape from the loading site.
A small fraction of the 9-1-1 ring placed around the duplex and
no longer in contact with Rad17-RFC, and thus freely diffusible
around the duplex, would not be detected by this method. We
reasoned that such molecules might be more readily detected by
electron microscopy and analyzed the Rad17-RFC9-1-1DNA
complexes by electron microscopy.
Fig. 7A shows an EM picture of a nicked plasmid that was
incubated with Rad17-RFC9-1-1 complex. The size and shape
of the complex, indicated by a large arrow, are consistent with
that of a Rad17-RFC9-1-1 supercomplex, whereas those indi-
cated by small arrows are consistent with the shape and size of
the 9-1-1 complex. Thus, a plausible explanation of the data in
Fig. 7A is that the Rad17-RFC at the nick site has already loaded
two 9-1-1 clamps around the DNA and that these two have
diffused away from the loading site while the complex is in the
process of loading a third 9-1-1 clamp. Indeed, such complexes
were not observed when the reaction was performed in the
absence of ATP (data not shown). Similar experiments were also
performed with a 718-bp duplex with a 40-nt gap, and some
representative photographs from those loading experiments are
shown in Fig. 7 B–D. Fig. 7D shows an EM picture of Rad17-RFC
bound to the gapped DNA. Based on EM analyses of numerous
Rad17-RFC and 9-1-1 complexes, it is safe to assume that the
DNA-bound proteins in Fig. 7 B and C are 9-1-1 rings (flat and
hollow) around the DNA when compared with the compact and
relatively dense Rad17-RFC shown in Fig. 7D. EM pictures of
gel-excluded material from reactions lacking Rad17-RFC failed
to detect 9-1-1 rings around the DNA (data not presented). Thus,
whereas hydrodynamic experiments support only recruitment of
9-1-1 by Rad17-RFC, single molecule experiments by electron
microscopy clearly support loading of 9-1-1 rings onto DNA by
the Rad17-RFC clamp loader.
Fig. 6. Sliding assay for PCNA and the 9-1-1 complex. (A) PCNA loading. RFC
(2 pmol) and 32P-labeled PCNA (0.6 pmol) were assembled on nicked pBlue-
script () or BamHI-linearized nicked pBluescript (■ ) (0.15 pmol) in a 50-l
reaction mixture as described in Materials and Methods. The mixture was
incubated in 2 mM ATP for 5 min and then loaded onto a 5-ml Bio-Gel A-15M
and eluted as described in Materials and Methods. (B) 9-1-1 loading. Rad17-
RFC (2 pmol) and 32P-labeled 9-1-1 (0.6 pmol) were assembled on nicked
pBluescript (F) or BamHI-linearized nicked pBluescript (E) (0.15 pmol) in a
50-l reaction mixture as described in Materials and Methods. The mixture
was incubated in 2 mM ATPS for 5 min and then supplemented with 8 mM
ATP and incubated for 5 min. The mixture was loaded onto a 5-ml Bio-Gel
A-15M and eluted as described in Materials and Methods.
Fig. 7. Electron microscopic evidence for loading of the 9-1-1 complex by
Rad17-RFC. (A) 9-1-1 loading on a 6.9-kb nicked plasmid. Large white arrow
indicates presumed supercomplex of Rad17-RFC and 9-1-1; small white arrows
indicate loaded 9-1-1 protein complexes. (B–D) Loaded 9-1-1 complexes (B and
C) and Rad17-RFC (D) on a 718-bp circular template with a 40-nt single strand
gap. Samples were directly mounted onto thin carbon-coated foils and rotary
shadowed with tungsten. Shown in reverse contrast. [Bar  1,000 bp (A);  500
bp (B–D).]









It seems that human cells have at least three RFC-like complexes
with specialized functions: RFC for replication, Rad17-RFC for
the DNA damage checkpoint, and Ctf18-RFC for sister chro-
matid separation (24, 25). The only known function of replicative
RFC is to load PCNA onto DNA and thus form a clamp that
enhances the processivity of replicative polymerases (15). It has
been assumed that the other RFC analogs function in a similar
manner. Indeed, analyses of Rad17-RFC and the 9-1-1 complex
by electron microscopy revealed structures very similar to RFC
and PCNA, respectively, suggesting functional similarity as well
(14, 26). Despite the structural similarities, however, it has been
experimentally challenging to demonstrate that Rad17-RFC
9-1-1 behaves exactly like the classic clamp loaderclamp com-
plex. This may be due, in part, to the intrinsic differences
between the ways these two complexes function. However, part
of the problem undoubtedly stems from the unique physico-
chemical properties of the Rad17–RFC complex. This complex
is prone to aggregate in ionic strength below 0.3 M and in the
absence of a nucleotide cofactor (data not presented). The
necessity to work within these constraints has made it difficult to
study the complex biochemically. Despite these limitations, in
this paper we have been able to show the formation of a
Rad17-RFC9-1-1 supercomplex and the recruitment of the
9-1-1 ring to DNA in a manner analogous to recruitment of
PCNA to DNA by RFC. Although it was not possible to
demonstrate unambiguously that Rad17-RFC loads the 9-1-1
complex onto DNA by using hydrodynamic methods, we did
obtain evidence from electron microscopic analysis that Rad17-
RFC does load the 9-1-1 complex onto DNA. We believe the
difficulty in demonstrating 9-1-1 loading compared with PCNA
loading may be due to stronger interactions between Rad17-
RFC and the 9-1-1 complex, which could reduce the rate with
which the loaded 9-1-1 complex moves away from Rad17-RFC.
Nevertheless, the EM results suggest that with further optimi-
zation of the reaction conditions, we will be able to demonstrate
9-1-1 loading by hydrodynamic methods.
Assuming that the Rad17-RFC9-1-1 pair functions similarly
to the RFCPCNA pair, then the question arises as to why
Rad17-RFC9-1-1 is required at all. Clearly, the replication
machinery and the checkpoint signaling system involve quite
distinct pathways with their unique protein components, and the
utilization of two distinct clamp loaderDNA clamps for these
two pathways may make mechanistic sense. It must be noted that
we find that Rad17-RFC is capable of interacting with PCNA;
however, we do not detect any loading of PCNA by Rad17-RFC.
Finally, how a clamp loaderpolymerase clamp functions in
the DNA damage checkpoint is an interesting question. In
current models for the checkpoint, there are no suggestions of a
DNA clamp for enhancing the processivity of a polymerase or
any other DNA-traversing enzyme. Rather, these models suggest
that the Rad17-RFC9-1-1 complex and ATRATM accumulate
at the site of damage (a single-strand DNA gap or a double-
strand break) and recruit the signal transduction kinases to these
sites to activate the checkpoint. There is no obvious role in these
models for a clamp loaderclamp complex. We expect that
further biochemical analysis will help refine the models and
explain why such a complex is needed.
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